aus 2012:


    IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas.

       Falini B, Agostinelli C, Bigerna B, Pucciarini A, Pacini R, Tabarrini A, Falcinelli F, Piccioli M, Paulli M, Gambacorta M, Ponzoni M, Tiacci E, Ascani S, Martelli MP, Dalla Favera R, Stein H, Pileri SA. Falini B, Agostinelli C, Bigerna B, Pucciarini A, Pacini R, Tabarrini A, Falcinelli F, Piccioli M, Paulli M,
Gambacorta M, Ponzoni M, Tiacci E, Ascani S, Martelli MP, Dalla Favera R, Stein H, Pileri SA.
       Zusammenfassung, 09/2012
      ↵ "Histopathology", Abstract, 09/2012

    A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect
    unmutated A20 by immunohistology.
       Hirsch B, Grünbaum M, Wagner F, Bi Y, Lucka L, Du MQ, Stein H, Dürkop H.Autoren
       "Histopathology", 05/2012
       ↵ [PMID:22393903]

    Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with
    advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label,
    phase 3 non-inferiority trial.
       Engert A, Haverkamp H, Kobe C, Markova J, Renner C, Ho A, Zijlstra J, Král Z, Fuchs M, Hallek M, Kanz L, Döhner H, Dörken B, Engel N, Topp M, Klutmann S, Amthauer H, Bockisch A, Kluge R, Kratochwil C, Schober O, Greil R, Andreesen R, Kneba M, Pfreundschuh M, Stein H, Eich HT, Müller RP, Dietlein M, Borchmann P, Diehl V; German Hodgkin Study Group; Swiss Group for Clinical Cancer Research; Arbeitsgemeinschaft Medikamentöse Tumortherapie. Engert A, Haverkamp H, Kobe C, Markova J, Renner C, Ho A, Zijlstra J, Král Z, Fuchs M, Hallek M, Kanz L,
Döhner H, Dörken B, Engel N, Topp M, Klutmann S, Amthauer H, Bockisch A, Kluge R, Kratochwil C, Schober
O, Greil R, Andreesen R, Kneba M, Pfreundschuh M, Stein H, Eich HT, Müller RP, Dietlein M, Borchmann P,
Diehl V; German Hodgkin Study Group; Swiss Group for Clinical Cancer Research; Arbeitsgemeinschaft
Medikamentöse Tumortherapie.
       Zusammenfassung, 05/2012
↵ "Lancet", Volltext, 05/2012


    Dose-intensification in early unfavorable Hodgkin's lymphoma: final
    analysis of the German Hodgkin Study Group HD14 trial.
       von Tresckow B, Plütschow A, Fuchs M, Klimm B, Markova J, Lohri A, Kral Z, Greil R, Topp MS, Meissner J, Zijlstra JM, Soekler M, Stein H, Eich HT, Mueller RP, Diehl V, Borchmann P, Engert A. von Tresckow B, Plütschow A, Fuchs M, Klimm B, Markova J, Lohri A, Kral Z, Greil R, Topp MS,
Meissner J, Zijlstra JM, Soekler M, Stein H, Eich HT, Mueller RP, Diehl V, Borchmann P, Engert A.
       Zusammenfassung, 03/2012
      ↵ "Journal of clinical Oncology", Abstract, 03/2012

    First case report of a peripheral T-cell lymphoma, not otherwise specified,
     of the central nervous system in a child.
       Lueth M, Stein H, Spors B, Henze G, Driever PH.Autoren
       Zusammenfassung, 03/2012
      ↵ "Journal of Pediatric Hematology and Oncology", Abstract, 03/2012

------------------------------------------------------------------------------------⇑ oben

    Rapidly progressive B-cell dominated inflammatory neuropathy and littoral cell angioma
    of the spleen associated with plasmablastic B-cell lymphoma.
       Nico Melzer, Peter Josef Barth, Klaus-Michael Müller, Hans-Dieter Foss, Utz Krug, Matthias Schilling, Martin Marziniak, Oliver Martin Grauer & Heinz Wiendl. Nico Melzer, Peter Josef Barth, Klaus-Michael Müller, Hans-Dieter Foss, Utz Krug, Matthias Schilling,
Martin Marziniak, Oliver Martin Grauer & Heinz Wiendl.
       "Leuk Lymphoma", published ahead of print, 01/2012
       ↵ [PMID:22098375]

    Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic
    large cell lymphoma cells but not in Hodgkin lymphoma cells.
       Suzuki O, Hirsch B, Abe M, Dürkop H, Stein H.Autoren
       Zusammenfassung, 10/2011
      ↵ "Laboratory Investigation", Volltext, 02/2012